戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 GCA relapse heralded by symptoms of isolated polymyalgia rheumatica (1 case versus 5 in the placebo g
2                                              Polymyalgia rheumatica (PMR) and giant cell arteritis (G
3                                              Polymyalgia rheumatica (PMR) has an abrupt onset of infl
4 omic basis for joint disease localization in polymyalgia rheumatica (PMR) is poorly understood.
5                    To evaluate the impact of polymyalgia rheumatica (PMR) on clinical outcomes and qu
6                   Imaging studies in GCA and polymyalgia rheumatica (PMR) suggest that vasculitis can
7                             In patients with polymyalgia rheumatica (PMR), a subclinical variant of G
8 /or visual abnormalities, fever, concomitant polymyalgia rheumatica (PMR), and histologic evidence of
9 nifestations are headache, jaw claudication, polymyalgia rheumatica (PMR), and visual symptoms, but 4
10 ic lupus erythematosus, psoriatic arthritis, polymyalgia rheumatica (PMR), giant cell arteritis, anky
11 ous cardiovascular diseases in patients with polymyalgia rheumatica (PMR).
12  of Rheumatology classification criteria for polymyalgia rheumatica (PMR).
13 toms and clinical features characteristic of polymyalgia rheumatica and/or giant cell arteritis (GCA)
14                                              Polymyalgia rheumatica is a chronic, inflammatory disord
15                                              Polymyalgia rheumatica is an inflammatory disease that a
16 val (CI): 1.1-1.2), P=9.8 x 10(-11)) and for polymyalgia rheumatica near C6orf10 at rs6910071 (OR=1.5
17                                              Polymyalgia rheumatica occurred with similar frequency i
18 such as anti-interleukin 6, in patients with polymyalgia rheumatica that is refractory to glucocortic
19                             One patient with polymyalgia rheumatica who developed the inhibitor while
20 with nonstenosing vasculitis; and "isolated" polymyalgia rheumatica with myalgias, systemic inflammat
21 timate of 21 million for 1995), 711,000 have polymyalgia rheumatica, 228,000 have giant cell arteriti
22 nifestations are headache, jaw claudication, polymyalgia rheumatica, and visual symptoms.
23   This issue provides a clinical overview of polymyalgia rheumatica, focusing on risk factors, diagno
24 ases, infections, and malignancies can mimic polymyalgia rheumatica.
25 ases in acute phase reactants are typical of polymyalgia rheumatica.
26            Several other disorders can mimic polymyalgia rheumatica.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。